Treatment Selection in Metastatic and Castration Resistant Prostate Cancer Optimizing Outcomes and Preserving Patient Quality of Life

Opinion
Video

Drs. Shore & McKay discuss treatment selection for metastatic & castration-resistant prostate cancer, the current landscape, and key factors guiding personalized treatment decisions.

Related Videos
Rohan Garje, MD
Jeffrey P. Townsend, PhD
Rohan Garje, MD
Video  10 -"Real-World Evidence on Second-Line Therapy Selection and Outcomes"
Video  9 - "Additional Second-Line Treatments for HCC"
A panel of 4 experts on colorectal cancer
Josep Maria Piulats Rodriguez, MD, PhD
Video 8 - "The Evolving Landscape of Second-Line Therapies in HCC Management"
Video 7 - "Comorbidity Considerations for HCC Treatment"
Angela Jia, MD, PhD, of University Hospitals